Theophylline in 5% Dextrose
"The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the di"...
Theophylline 5% Dextrose Injection Excel
Theophylline in 5% Dextrose Injections USP (theophylline in dextrose excel container)
Do not admix with other drugs.
Theophylline in 5% Dextrose Injections USP (theophylline in dextrose excel container) are sterile, nonpyrogenic solutions intended for intravenous administration, prepared from theophylline and dextrose in Water for Injection USP.
Composition - Each 100 mL contains
|Solution||Anhydrous Theophylline USP||Hydrous Dextrose USP||pH||Calculated Osmolarity mOsmol/liter|
|0.08% Theophylline in 5% Dextrose Injection USP||80 mg||5 g||4.7 (3.5-6.5)||255|
|0.16% Theophylline in 5% Dextrose Injection USP||160 mg||5 g||4.7 (3.5-6.5)||260|
Water for Injection USP, qs
Theophylline is structurally classified as a methylxanthine. It occurs as a white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and is represented by the following structural formula:
The formulas of the active ingredients are:
Theophylline, Anhydrous, USP
Hydrous Dextrose USP
The molecular formula of anhydrous theophylline is C7H8N4O2 with a molecular weight of 180.17. The molecular formula of hydrous dextrose is C6H12O6•H2O with a molecular weight of 198.17.
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a tamper evident plastic protector. Refer to the Directions for Use of the container.
Last reviewed on RxList: 8/28/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Theophylline 5% Dextrose Injection Excel Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.